Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2013.04.022 ◽

2013 ◽

Vol 64 (1) ◽

pp. 167 ◽

Author(s):

J. Kellogg Parsons

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13690956.793153050 ◽

2012 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13690956.15750058 ◽

2012 ◽

Author(s):

Yoshihiko Hirao ◽

Kiyohide Fujimoto

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13690956.15667056 ◽

2012 ◽

Author(s):

Robert Huddart

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(11)61619-x ◽

2012 ◽

Vol 379 (9821) ◽

pp. 1103-1111 ◽

Author(s):

Neil E Fleshner ◽

M Scott Lucia ◽

Blair Egerdie ◽

Lorne Aaron ◽

Gregg Eure ◽

...

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled Trial

European Urology ◽

10.1016/j.eururo.2012.03.028 ◽

2012 ◽

Vol 61 (6) ◽

pp. 1265-1266 ◽

Author(s):

Bertrand Tombal ◽

Frederic Lecouvet

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Yearbook of Urology ◽

10.1016/j.yuro.2012.07.006 ◽

2012 ◽

Vol 2012 ◽

pp. 52-53 ◽

Author(s):

G.L. Andriole

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-Blind, Placebo-Controlled Trial

The Journal of Urology ◽

10.1016/j.juro.2012.03.102 ◽

2012 ◽

Vol 188 (1) ◽

pp. 110-111 ◽

Author(s):

Patrick C. Walsh

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13690956.15340056 ◽

2012 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13690956.793455838 ◽

2012 ◽

Author(s):

Laurence Klotz

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text

Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13690956.15104065 ◽

2012 ◽

Author(s):

James Catto ◽

Kate Linton

Keyword(s):

Prostate Cancer ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Management ◽

Prostate Cancer Management

Download Full-text